These data concur with previously published studies showing that hypertension is associated with decreased insulin clearance [10, 12] and that administration of the α1-adrenergic agonist phenylephrine during hyperinsulinemic euglycemic clamp acutely diminishes insulin clearance in healthy volunteers [19]. Here, INS is linked to hypertensive disorder.